JP2011512349A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512349A5
JP2011512349A5 JP2010546446A JP2010546446A JP2011512349A5 JP 2011512349 A5 JP2011512349 A5 JP 2011512349A5 JP 2010546446 A JP2010546446 A JP 2010546446A JP 2010546446 A JP2010546446 A JP 2010546446A JP 2011512349 A5 JP2011512349 A5 JP 2011512349A5
Authority
JP
Japan
Prior art keywords
layer
release
coating
alcohol
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010546446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512349A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2009/000106 external-priority patent/WO2009122431A2/en
Publication of JP2011512349A publication Critical patent/JP2011512349A/ja
Publication of JP2011512349A5 publication Critical patent/JP2011512349A5/ja
Pending legal-status Critical Current

Links

JP2010546446A 2008-02-15 2009-02-16 経口放出制御錠剤 Pending JP2011512349A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN339MU2008 2008-02-15
PCT/IN2009/000106 WO2009122431A2 (en) 2008-02-15 2009-02-16 Oral controlled release tablet

Publications (2)

Publication Number Publication Date
JP2011512349A JP2011512349A (ja) 2011-04-21
JP2011512349A5 true JP2011512349A5 (enExample) 2012-04-05

Family

ID=40955347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546446A Pending JP2011512349A (ja) 2008-02-15 2009-02-16 経口放出制御錠剤

Country Status (10)

Country Link
US (1) US20090208572A1 (enExample)
EP (1) EP2242485A4 (enExample)
JP (1) JP2011512349A (enExample)
KR (1) KR20100136967A (enExample)
CN (1) CN102026628A (enExample)
BR (1) BRPI0908114A2 (enExample)
CA (1) CA2715584A1 (enExample)
MX (1) MX2010008861A (enExample)
WO (1) WO2009122431A2 (enExample)
ZA (1) ZA201006793B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103540568A (zh) * 2002-04-26 2014-01-29 米迪缪尼有限公司 制备流感病毒的多质粒系统
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
TWI331803B (en) 2002-08-19 2010-10-11 Univ Columbia A single-shot semiconductor processing system and method having various irradiation patterns
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2005062820A2 (en) * 2003-12-23 2005-07-14 Medimmune Vaccines, Inc Multi plasmid system for the production of influenza virus
CA2690196A1 (en) * 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
WO2010139111A1 (en) 2009-06-02 2010-12-09 Dow Global Technologies Inc. Sustained release dosage form
US20120207825A1 (en) * 2009-09-17 2012-08-16 Sunilendu Bhushan Roy Pharmaceutical compositions for reducing alcohol-induced dose dumping
US8901113B2 (en) * 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
EP2714015B1 (en) * 2011-06-01 2017-03-15 FMC Corporation Controlled release solid dose forms
ES2691982T3 (es) 2012-11-30 2018-11-29 Acura Pharmaceuticals, Inc. Liberación autorregulada de un principio activo farmacéutico
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
EA030138B1 (ru) * 2016-06-15 2018-06-29 Общество С Ограниченной Ответственностью "Фармадиол" Фармацевтические композиции, включающие антикоагулянт n-(5-хлорпиридин-2-ил)-2-({4-[этанимидоил(метил)амино]бензоил}амино)-5-метилбензамид
IT201800011125A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide comprendenti matrici monolitiche complesse per la somministrazione cronotropica di medicamenti nel tratto gastroenterico
UA130040C2 (uk) * 2020-05-08 2025-10-22 Янссен Фармацевтика Нв Види лікування раку передміхурової залози за допомогою комбінацій абіратерону ацетату та нірапарибу
WO2025137498A1 (en) * 2023-12-20 2025-06-26 Areteia Therapeutics, Inc. Matrix tablets of dexpramipexole and methods of manufacturing and use thereof
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
WO1993006821A1 (fr) * 1991-10-04 1993-04-15 Yoshitomi Pharmaceutical Industries, Ltd. Comprime a liberation prolongee
EP0621032B1 (en) * 1993-04-23 2000-08-09 Novartis AG Controlled release drug delivery device
RU2134103C1 (ru) * 1993-05-15 1999-08-10 Берингер Маннхайм ГмбХ Таблетка с улучшенной биодоступностью биологически активного вещества и вещество, повышающее биодоступность
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
JP5170723B2 (ja) * 1997-01-10 2013-03-27 アボット・ラボラトリーズ 活性薬剤の制御放出用錠剤
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
EP1967185A1 (en) * 1999-12-23 2008-09-10 Pfizer Products Inc. Hydrogel-driven drug dosage form
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
JP4426286B2 (ja) * 2001-07-10 2010-03-03 テバ ファーマシューティカル インダストリーズ リミティド ０次、０次−二相性、上昇型又は下降型薬物放出のための薬物送達システム
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
AU2004283565C1 (en) * 2003-09-19 2011-10-27 Sun Pharma Advanced Research Company Limited Oral drug delivery system
US20060193911A1 (en) * 2005-02-28 2006-08-31 Penwest Pharmaceuticals Co., Controlled release venlafaxine formulations
JP5020931B2 (ja) * 2005-03-14 2012-09-05 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 経口薬剤送達システム
EP1895989A2 (en) * 2005-06-03 2008-03-12 Egalet A/S A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
WO2007057762A2 (en) * 2005-11-16 2007-05-24 Pfizer Limited Osmotic bi-layer tablet
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration

Similar Documents

Publication Publication Date Title
JP2011512349A5 (enExample)
CN111405895B (zh) 一种控释药物组合物及其制备方法
WO2009122431A3 (en) Oral controlled release tablet with reduced burst effect
KR101241624B1 (ko) 안지오텐신-ⅱ-수용체 차단제를 포함하는 약제학적 제제
JP4706785B2 (ja) 経口投与用粒子状医薬組成物
JP5986984B2 (ja) 積層錠剤、その製造方法、および、層剥離抑制方法
CN103096881B (zh) 含有具有不愉快味道的药物的膜制剂
ES2525648T3 (es) Formulaciones galénicas que comprenden Aliskiren
JP2013522373A5 (enExample)
US20110229570A1 (en) Orally rapidly disintegrating tablet and process for producing same
JP2010527347A5 (enExample)
WO2008140460A1 (en) Solid form
CN101711752A (zh) 一种苯并异噁唑类衍生物的控释制剂及其制备方法
HRP20240564T1 (hr) Novi farmaceutski sastav
WO2013030725A1 (en) Methods for treating cardiovascular disorders
WO2004064815A8 (en) Oral dosage formulation
JP2016516698A5 (enExample)
KR20130010463A (ko) 고형 제제
CN103948557A (zh) 一种新型控释片
KR20130010464A (ko) 고형 제제
WO2007132296B1 (en) Multilayer tablet
KR20110130441A (ko) 고형 제제
RU2221559C1 (ru) Препарат диклофенак натрия длительного действия
RU2611339C2 (ru) Фармацевтические композиции с пролонгированным высвобождением для лечения цереброваскулярных расстройств
TWI394594B (zh) 錠劑藥學組成物及其製造方法